Race for coronavirus treatment

Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.

The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.

The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.

It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.

The trial is due to start next week.

Last local news

Evening Update Monday 18 January 2021

A new study has estimated that the British coronavirus variant accounts for 1.4% of all newly diagnosed coronavirus cases in France. The French Nation... Evening Update Monday 18 January 2021 Read More

18/01/2021

Lunchtime News Monday 18th January 2021

A pirate platform has caused chaos on the first day of the opening of a vaccination centre in Toulon in the Var. ... Lunchtime News Monday 18th January 2021 Read More

18/01/2021

French and Riviera News Monday 18th January 2021

As the vaccination campaign against Covid continues in France with today, all people over 75 and at high risk being vaccinated, the Prefect of the Alp... French and Riviera News Monday 18th January 2021 Read More

18/01/2021